Home-Logo
left-arrow
person

Dr Virginie Lam

EMCR Chair and Senior Research Fellow
Curtin School of Population Health

NHMRC Early Career Research Fellow

My passion for brain health began during my undergraduate studies in biomedical science, where I became deeply interested in how nutrition, metabolism, and lifestyle collectively shape brain function. This curiosity, combined with my enthusiasm for health and fitness, has been the foundation of my research journey. I am particularly inspired by the intricate connections between the body and the brain, and how factors such as diet and metabolic health can profoundly influence cognitive wellbeing.      


About

Dr Virginie Lam is a neuroscientist and biomedical researcher based at Curtin University in Perth, Australia. She works within the Curtin Health Innovation Research Institute and the Curtin Medical Research Institute, focusing on the biological mechanisms that contribute to neurological and neurodegenerative diseases.


Dr Lam is recognised as an early career leader in neuroscience research, with expertise spanning clinical biochemistry, cerebrovascular biology, and neurodegenerative disease research. Her work integrates laboratory studies, imaging techniques, and clinical research to understand how brain function deteriorates in conditions such as Alzheimer’s disease and multiple sclerosis.


Through her work at Curtin, Dr Lam contributes to a broader research effort investigating how the brain’s vascular and metabolic systems influence neurological disease. This research aims to identify early risk factors, develop treatments, and improve long term outcomes for people with neurodegenerative disorders.

Dr Virginie Lam is an active member of several professional organisations, including:

  • Australian Society for Medical Research
  • Australasian Neuroscience Society
  • EMCR Brain Science Network
  • Australian Vascular Biology Society
  • Australian Atherosclerosis Society
  • International Society of Chylomicrons in Disease
  • Chair, Early & Mid-Career Researcher (EMCR) Committee, Cerebrovascular Biology Australia Working Group (2022-)
  • Associate Investigator, Curtin Health Innovation Research Institute, Neurodegeneration and Chronic Pain Domain (2020-)
  • Associate Investigator, Curtin Clinical Trials and Data Infrastructure Platform, Curtin University (2021-)
  • Secretary, Cerebrovascular Biology Australia Working Group (2019-)
  • Co-Chair of the Curtin Health Innovation Research Institute and enAble Institute Early & Mid-Career Researcher (EMCR) Committee (2019-)
  • Lead, Networking and Communications Committee, Curtin University Early to Mid- Career Researcher Network Steering Committee (2021-)
  • Category B Member for the Curtin University Animal Ethics Committee (2021-)
  • Organiser of the Curtin Health Innovation Research Institute Early- to Mid-Career Mentoring Programme (2019-)
  • Early Career Representative for the Curtin Health Innovation Research Institute Domain Leadership Group (2020-)
  • Scientific Advisory Member for the Curtin University Human Ethics Committee Health Sciences (2020-)

Dr Lam’s research excellence has been recognised through numerous competitive awards and grants, including:

  • Bryant Stokes Neurological Research Fund (2022 to 2023)
  • Raine Medical Research Foundation Priming Grant (2022 to 2024)
  • WA Future Health Research and Innovation Fund Grant (2022 to 2023)
  • Curtin University Faculty Research Seed Funding Award (2021 to 2022)
  • National Health and Medical Research Council IDEAS Grant (2021 to 2023)
  • Medical Research Future Fund and National Health and Medical Research Council Research Grant for Neurological Disorders (2020 to 2024)
  • National Health and Medical Research Council Peter Doherty Early Career Fellowship (2019 to 2022)

Dr Lam has also received several accolades recognising her research contributions:

  • Best Early Career Researcher Publication Award (2021)
  • Best Early Career Research Presentation, SWAN Conference (2018)

Research Focus

Dr Virginie Lam’s research focuses on understanding the biological mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s disease, multiple sclerosis, and cognitive impairment associated with ageing. Her work investigates how changes in the brain’s vascular system, metabolism, and lipid biology contribute to neurological decline, with the aim of identifying therapies that can prevent or slow disease progression.


A central theme of her research is the relationship between brain blood vessels and neurological health. She studies how the integrity of brain capillaries affects cognitive function and explores how micronutrients, vascular disruption, and metabolic factors influence memory and brain health.


Dr Lam also examines the role of lipids and nutrition in neurological disease. Her research investigates how dietary fats and bioactive lipids influence brain function and repair processes, including whether specific lipid compounds can support myelin regeneration, which is critical in conditions such as multiple sclerosis.


In multiple sclerosis research, she explores lipid based therapies, dietary strategies, and advanced MRI techniques to better understand disease progression and support myelin repair. Her work in Alzheimer’s disease research examines how amyloid beta proteins and lipid metabolism contribute to neurodegeneration, including whether targeting lipid pathways may reduce amyloid accumulation.


Alongside laboratory research, Dr Lam is actively involved in clinical and translational research. She has served as an Associate Investigator and clinical trial manager for Alzheimer’s disease studies, coordinating multi site trials and supporting the translation of laboratory discoveries into potential treatments.

Research Team

Caitlin Moralee

Clinical Trials Project Officer

Sarah Schwab

Clinical Trials Project Officer

Isobel Thomas-Bland

PhD Student

Diana Patalwala

PhD Student

Emily Redwood

PhD Student

Publications

ABSTRACT

Zinc ions (Zn2+) are the second most abundant trace metal ion in the brain of rodents and primates, often serving functions as a structure-stabilizing element or catalytic role. There is an additional pool of Zn2+, ∼15% of total brain Zn2+, which exists in a labile chemical form in a specific subset of glutamatergic neurons (‘zinergic’ or ‘zincergic’ neurons). The labile pool of Zn2+ is now well established to be critical for healthy memory function, with disturbance to the labile Zn2+ pool implicated in diminished memory performance during the ageing process or neurodegeneration. The chemical form of Zn2+ in the labile Zn2+ pool has however, remained unknown, largely due to the difficulty of imaging metal speciation for ‘spectroscopically silent’ metals such as Zn2+. In this study, we have developed X-ray absorption near edge structure (XANES) spectroscopic protocols to enable chemically specific imaging of Zn2+ speciation in murine brain (hippocampal) tissue. The protocols capitalise on the unique sensitivity of the XANES spectral region to metal ion coordination environment, enabling a direct in situ measurement of metal speciation. Key findings of our method development are characterisation of the effects of sample preparation on metal speciation, and revelation that Zn2+ coordination with histidine is likely to be the dominant coordination environment of the labile Zn2+ pool in the murine hippocampus.


Hollings, A. L., M. Willans, V. Lam, R. Takechi, J. C. L. Mamo, V. Mitchell, M. D. De Jonge, D. L. Howard, G. Ellison, and M. J. Hackett. 2026. Imaging zinc speciation in the mouse hippocampus with µXANES Spectroscopic mapping.Metallomics 18 (1)
ABSTRACT

Natural aging is associated with mild memory loss and cognitive decline, and age is the greatest risk factor for neurodegenerative diseases, such as Alzheimer’s disease. There is substantial evidence that oxidative stress is a major contributor to both natural aging and neurodegenerative disease, and coincidently, levels of redox active metals such as Fe and Cu are known to be elevated later in life. Recently, a pronounced age-related increase in Cu content has been reported to occur in mice and rats around a vital regulatory brain region, the subventricular zone of lateral ventricles. In our study herein, we have characterized lateral ventricle Cu content in a unique murine model of accelerated aging, senescence accelerated mouse-prone 8 (SAMP8) mice. Our results confirm an age-related increase in ventricle Cu content, consistent with the studies by others in wild-type mice and rats. Specifically, we observed Cu content to increase over the time frame 1 to 5 months and 5 to 9 months, but interestingly, no significant increase occurred between 9 and 12 months (although brain Cu content at 12 months was significantly elevated relative to 1 and 5 month-old animals). Despite the magnitude of Cu increase observed within the cells that comprise the subventricular zone of lateral ventricles (average 3 mM Cu, with isolated subcellular concentrations of 17 mM), we did not detect spectroscopic markers of thiol oxidation, protein aggregation, or lipid oxidation. The lack of evidence for oxidative stress in ex vivo animal tissue is in contrast to in vitro studies demonstrating that thiol, protein, and lipid oxidation is pronounced at these Cu concentrations. We suggest that our findings most likely indicate that the Cu ions in this brain region are sequestered in an unreactive form, possibly extended chains of Cu-thiolate complexes, which do not readily redox cycle in the aqueous cytosol. These results also appear to partially challenge the long-held view that age-related increases in brain metal content drive oxidative stress as we did not observe a concomitant association between age-related Cu increase and markers of oxidative stress, nor did we observe a net increase in Cu content between mice aged 9 and 12 months.

Hollings, A. L., G. C. Ellison, M. Willans, V. Lam, T. Munyard, A. R. Remy, R. Takechi, J. C. L. Mamo, S. Webb, E. J. New, and 6 more contributors. 2025.Subventricular Accumulation of Cu in the Aging Mouse Brain Does Not Associate with Anticipated Increases in Markers of Oxidative Stress.ACS Chemical Neuroscience 16 (3): 292-302

Nutraceutical and pharmacological intervention in neurological disorders

Dr Virginie Lam

Find a researcher

Search for researchers at Curtin MRI

Search by name

Search by area of research